Qingdao Baheal Medical INC. (301015) — Cash Flow Quality Index
Qingdao Baheal Medical INC. (301015) has a Cash Flow Quality Index of 0.74x as of September 2025. Operating cash flow of CN¥230.38 Million is below net income of CN¥313.29 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 301015 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Qingdao Baheal Medical INC. Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Qingdao Baheal Medical INC. across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301015 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year earnings quality comparison for Qingdao Baheal Medical INC.. For live market cap and the full company financial profile, see 301015 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.97x | CN¥934.45 Million | CN¥474.69 Million | ▲ +85.5% |
| 2024 | 1.06x | CN¥813.85 Million | CN¥767.03 Million | ▼ -12.9% |
| 2023 | 1.22x | CN¥799.50 Million | CN¥656.31 Million | ▲ +101.8% |
| 2022 | 0.60x | CN¥305.75 Million | CN¥506.60 Million | ▲ +40.4% |
| 2021 | 0.43x | CN¥181.30 Million | CN¥421.64 Million | ▲ +200.4% |
| 2020 | -0.43x | CN¥-116.83 Million | CN¥272.71 Million | ▼ -295.6% |
| 2019 | 0.22x | CN¥45.96 Million | CN¥209.87 Million | ▲ +1.8% |
| 2018 | 0.22x | CN¥55.50 Million | CN¥258.10 Million | — |